Studienübersicht des TORM, Stand 06/2015
Die Studienübersicht kann hier im PDF Format heruntergeladen werden.
NSCLC - Met amplified - all lines
This study will assess the safety and efficacy of escalating doses INC280 when added to gefitinib in patients with lung cancer that are known to have dysregulation of the c-MET pathway and who have failed after benefiting on a prior treatment with either gefitinib or erlotinib.